Pls refer the attachment

Related Party TransactionsResults View source PDF Explain this filing

VIJAYA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.5%Reaction day

₹1208.00

prior close

₹1269.00

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.2%+5.4% vs market

Healthcare Service Provider peers, median of 27sector+1.5%+4.1% vs sector

On the reaction day the stock moved 5.4 pts more than Nifty Smallcap 250 and 4.1 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.4

10m

-2.7

15m

-2.5

30m

-2.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.5+0.2+5.4+1.5+4.1

Next day

+10.1-0.9+11.0+1.6+8.5

+6.0-3.9+9.9-0.2+6.2

+7.0-3.6+10.6+0.0+7.0

+6.0-3.6+9.5+1.2+4.8

+11.3-3.9+15.2-0.5+11.8

+8.0-4.3+12.3-0.2+8.2

15d

+3.4-3.2+6.6+0.7+2.7

+8.1-3.8+11.9-1.0+9.1

+10.1+1.1+9.0-3.1+13.2

+15.5+5.4+10.2-3.6+19.2

UpDownMarket · Nifty Smallcap 250Sector · Healthcare Service Provider peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vijaya Diagnostic Centre Ltd's Board Meeting on May 07, 2026 approved audited financial results for Q4 and FY 2026, recommended a final dividend of ₹2 per share (200% on ₹1 face value) subject to shareholder approval at AGM, and announced record date will be declared later. The Board granted 1,79,500 ESOPs to employees at ₹784 per option (average of last 3 months price with 20% discount) under VDCL ESOP Plan 2018. Independent Director Dr. D Nageshwar Reddy will not seek re-appointment for a second term from May 25, 2026 due to pre-occupation. The company also approved acquisition of MRI, EEG and NCV Services Business from its wholly-owned subsidiary Medinova Millennium MRI Services LLP for approximately ₹4.20 crore, expected to complete within 3 months. M/s. Santhosh & Associates were re-appointed as Cost Auditors for FY 2026-27.

Likely market impact

The dividend recommendation signals confidence in the company's financial health. The ESOP grant aligns employee interests with shareholders. The business acquisition from the subsidiary is a related party transaction that consolidates operations and may drive future growth.